Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Liver Diseases

  Free Subscription


1 AJR Am J Roentgenol
1 Am J Gastroenterol
3 BMC Cancer
2 BMC Gastroenterol
1 Br J Surg
1 Dig Dis Sci
1 Endoscopy
1 Eur J Pediatr
4 Eur Radiol
1 Gastroenterology
1 Gastrointest Endosc
10 Hepatology
1 J Clin Oncol
1 J Gastroenterol Hepatol
12 J Hepatol
1 PLoS Genet
1 PLoS One
2 Radiology
1 Semin Liver Dis
3 Transplant Proc

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJR Am J Roentgenol

  1. KUBALE R, Schneider G, Lessenich CPN, Buecker A, et al
    Ultrasound-Derived Fat Fraction for Hepatic Steatosis Assessment: Prospective Study of Agreement With MRI PDFF and Sources of Variability in a Heterogeneous Population.
    AJR Am J Roentgenol. 2024 Mar 20. doi: 10.2214/AJR.23.30775.
    PubMed         Abstract available

    Am J Gastroenterol

  2. TABISH M, Agarwal S, Gopi S, Rana R, et al
    Randomized controlled trial of Intravenous ferric-carboxymaltose vs oral iron to treat iron deficiency anemia after variceal bleed in patients with cirrhosis.
    Am J Gastroenterol. 2024 Mar 22. doi: 10.14309/ajg.0000000000002775.
    PubMed         Abstract available

    BMC Cancer

  3. MA Y, Gong Y, Qiu Q, Ma C, et al
    Research on multi-model imaging machine learning for distinguishing early hepatocellular carcinoma.
    BMC Cancer. 2024;24:363.
    PubMed         Abstract available

  4. FU J, Zheng L, Tang S, Lin K, et al
    Tumor burden score and carcinoembryonic antigen predict outcomes in patients with intrahepatic cholangiocarcinoma following liver resection: a multi?institutional analysis.
    BMC Cancer. 2024;24:358.
    PubMed         Abstract available

  5. LIANG Y, Zhong D, Zhang Z, Su Y, et al
    Correction: Impact of preoperative antiviral therapy on the prognosis of hepatitis B virus-related hepatocellular carcinoma.
    BMC Cancer. 2024;24:343.

    BMC Gastroenterol

  6. LI XM, Liu SL, He YJ, Shu JC, et al
    Using new indices to predict metabolism dysfunction-associated fatty liver disease (MAFLD): analysis of the national health and nutrition examination survey database.
    BMC Gastroenterol. 2024;24:109.
    PubMed         Abstract available

  7. FENG Z, Zhao F, Wang Z, Tang X, et al
    The relationship between sarcopenia and metabolic dysfunction-associated fatty liver disease among the young and middle-aged populations.
    BMC Gastroenterol. 2024;24:111.
    PubMed         Abstract available

    Br J Surg

  8. MARTIN-CULLELL B, Virgili AC, Riera P, Fumagalli C, et al
    Histopathological, Clinical, And Molecular (HICAM) score for patients with colorectal liver metastases.
    Br J Surg. 2024;111:znae016.
    PubMed         Abstract available

    Dig Dis Sci

  9. ARSHAD T, Vainer D, Khan H, Baral A, et al
    Development of Clinical Algorithm Utilizing Vibration-Controlled Transient Elastography to Detect Advanced Hepatic Fibrosis in Liver Transplant Recipients.
    Dig Dis Sci. 2024 Mar 18. doi: 10.1007/s10620-024-08366.
    PubMed         Abstract available


  10. WILEN J, Trieu JA, Baron TH
    Endoscopic ultrasound-guided embolization of a gastric varix by injection of RADA16 self-assembling peptide and coils.
    Endoscopy. 2024;56.

    Eur J Pediatr

  11. ZAHMATKESH A, Sohouli MH, Shojaie S, Rohani P, et al
    The effect of orlistat in the treatment of non-alcoholic fatty liver in adolescents with overweight and obese.
    Eur J Pediatr. 2024;183:1173-1182.
    PubMed         Abstract available

    Eur Radiol

  12. KIM TH, Woo S, Lee DH, Do RK, et al
    MRI imaging features for predicting macrotrabecular-massive subtype hepatocellular carcinoma: a systematic review and meta-analysis.
    Eur Radiol. 2024 Mar 20. doi: 10.1007/s00330-024-10671.
    PubMed         Abstract available

  13. NAKAZAWA Y, Okada M, Hyodo T, Tago K, et al
    Comparison between CT volumetry, technetium(99m) galactosyl-serum-albumin scintigraphy, and gadoxetic-acid-enhanced MRI to estimate the liver fibrosis stage in preoperative patients.
    Eur Radiol. 2024;34:2212-2222.
    PubMed         Abstract available

  14. CARUSO D, De Santis D, Del Gaudio A, Guido G, et al
    Low-dose liver CT: image quality and diagnostic accuracy of deep learning image reconstruction algorithm.
    Eur Radiol. 2024;34:2384-2393.
    PubMed         Abstract available

  15. RATA M, De Paepe KN, Orton MR, Castagnoli F, et al
    Evaluation of simultaneous multi-slice acquisition with advanced processing for free-breathing diffusion-weighted imaging in patients with liver metastasis.
    Eur Radiol. 2024;34:2457-2467.
    PubMed         Abstract available


  16. LLOVET JM, Heikenwalder M
    Atezolizumab Plus Bevacizumab in Advanced HCC: Efficacy in NASH-Specific Etiology.
    Gastroenterology. 2023;165:1308-1310.

    Gastrointest Endosc

  17. NORSA L, Morotti F, Mantegazza C, Meroni M, et al
    Mobile Health technology in pediatric esophagogastroduodenoscopy quality indicators assessment: results from a national program of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition.
    Gastrointest Endosc. 2024 Mar 19:S0016-5107(24)00180.
    PubMed         Abstract available


  18. April 2024 Hepatology Highlights.
    Hepatology. 2024;79:745-746.

  19. Erratum: HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma.
    Hepatology. 2024;79:E127.

  20. Erratum: Identification and characterization of a hepatic IL-13-producing ILC3-like population potentially involved in liver fibrosis.
    Hepatology. 2024;79:E128.

  21. MEROUEH C, Warasnhe K, Tizhoosh HR, Shah VH, et al
    Digital pathology and spatial omics in steatohepatitis: Clinical applications and discovery potentials.
    Hepatology. 2024 Mar 22. doi: 10.1097/HEP.0000000000000866.
    PubMed         Abstract available

  22. LADD AD, Duarte S, Sahin I, Zarrinpar A, et al
    Mechanisms of drug resistance in HCC.
    Hepatology. 2024;79:926-940.
    PubMed         Abstract available

  23. VOLKERT I, Fromme M, Schneider C, Candels L, et al
    Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progression.
    Hepatology. 2024;79:898-911.
    PubMed         Abstract available

  24. FRANSES JW, Duda DG
    Scirrhous HCC: Another 'omic thread in the HCC tapestry.
    Hepatology. 2024;79:747-748.

  25. ZHUANG Y, Ortega-Ribera M, Thevkar Nagesh P, Joshi R, et al
    Bile acid-induced IRF3 phosphorylation mediates cell death, inflammatory responses and fibrosis in cholestasis-induced liver and kidney injury via regulation of ZBP1.
    Hepatology. 2023 Sep 19. doi: 10.1097/HEP.0000000000000611.
    PubMed         Abstract available

  26. ALKHOURI N, Harisinghani M
    Letter to the Editor: Comparing quantitative MRI technologies in steatotic liver disease.
    Hepatology. 2024;79:E119-E120.

  27. LI J, Allen AM, Yin M
    Reply: Comparing quantitative MRI technologies in steatotic liver disease.
    Hepatology. 2024;79:E121-E122.

    J Clin Oncol

  28. GORDAN JD, Kennedy EB, Abou-Alfa GK, Beal E, et al
    Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update.
    J Clin Oncol. 2024 Mar 19:JCO2302745. doi: 10.1200/JCO.23.02745.
    PubMed         Abstract available

    J Gastroenterol Hepatol

  29. SUZUKI K, Yasui Y, Tsuchiya K, Matsumoto H, et al
    Impact of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
    J Gastroenterol Hepatol. 2024 Mar 17. doi: 10.1111/jgh.16532.
    PubMed         Abstract available

    J Hepatol

  30. XU L, Zhang Y, Lin Z, Deng X, et al
    FASN-mediated fatty acid biosynthesis remodels immune environment in Clonorchis sinensis infection-related intrahepatic cholangiocarcinoma.
    J Hepatol. 2024 Mar 18:S0168-8278(24)00199-5. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available

  31. YASHASWINI CN, Qin T, Bhattacharya D, Amor C, et al
    Phenotypes and ontogeny of senescent hepatic stellate cells in metabolic dysfunction-associated steatotic liver disease.
    J Hepatol. 2024 Mar 18:S0168-8278(24)00197-1. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available

  32. YANG A, Zhu X, Zhang L, Ding Y, et al
    Transitioning from NAFLD to MAFLD and MASLD: Consistent prevalence and risk factors in a Chinese cohort.
    J Hepatol. 2024;80:e154-e155.

  33. KIRK FT, Munk DE, Swenson ES, Quicquaro AM, et al
    Effects of tetrathiomolybdate on copper metabolism in healthy volunteers and in patients with Wilson disease.
    J Hepatol. 2024;80:586-595.
    PubMed         Abstract available

  34. RETAT L, Webber L, Jepsen P, Martin A, et al
    Preventing liver disease with policy measures to tackle alcohol consumption and obesity: The HEPAHEALTH II study.
    J Hepatol. 2024;80:543-552.
    PubMed         Abstract available

  35. CHEN J, Zhou H, Liu K
    Normal weight and central obesity as predictors of increased all-cause mortality in metabolic dysfunction associated steatotic liver disease.
    J Hepatol. 2024;80:e143-e145.

  36. SUZUKI H, Tanaka T, Yamaguchi S, Miwa K, et al
    Changing from NAFLD to MASLD: Similar prognosis of unresectable extrahepatic gastrointestinal cancer under chemotherapy between NAFLD and MASLD.
    J Hepatol. 2024;80:e150-e151.

  37. SHIRI AM, Zhang T, Bedke T, Zazara DE, et al
    IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction.
    J Hepatol. 2024;80:634-644.
    PubMed         Abstract available

  38. WANG CW, Huang PC, Dai CY, Huang JF, et al
    Comparative evaluation of pediatric fatty liver disease criteria: MASLD, ESPGHAN, NASPGHAN, and NAFLD - identifying the optimal pediatric label.
    J Hepatol. 2024;80:e157-e159.

  39. TREVISANI F, Vitale A, Kudo M, Kulik L, et al
    Merits and boundaries of the BCLC staging and treatment algorithm: Learning from the past to improve the future with a novel proposal.
    J Hepatol. 2024;80:661-669.
    PubMed         Abstract available

  40. NAYAGAM JS, Miquel R, Thompson RJ, Joshi D, et al
    Genetic cholestasis in children and adults.
    J Hepatol. 2024 Jan 30:S0168-8278(23)05305-9. doi: 10.1016/j.jhep.2023.

  41. MOGA L, Paradis V, Bruno O, Valla D, et al
    Hepatomegaly in a patient with a history of acute myeloid leukemia.
    J Hepatol. 2024;80:e139-e142.

    PLoS Genet

  42. SMAGRIS E, Shihanian LM, Mintah IJ, Bigdelou P, et al
    Divergent role of Mitochondrial Amidoxime Reducing Component 1 (MARC1) in human and mouse.
    PLoS Genet. 2024;20:e1011179.
    PubMed         Abstract available

    PLoS One

  43. YANG X, Wang S, Sun C, Xia Y, et al
    Causal effect of porphyria biomarkers on alcohol-related hepatocellular carcinoma through Mendelian Randomization.
    PLoS One. 2024;19:e0299536.
    PubMed         Abstract available


  44. LIU F, Bi M, Jing X, Ding H, et al
    Multiparametric US for Identifying Metabolic Dysfunction-associated Steatohepatitis: A Prospective Multicenter Study.
    Radiology. 2024;310:e232416.
    PubMed         Abstract available

    Noninvasive Identification of Metabolic Dysfunction-associated Steatohepatitis Globally.
    Radiology. 2024;310:e240436.

    Semin Liver Dis

  46. KODAMA T, Takehara T
    Molecular genealogy of metabolic-associated hepatocellular carcinoma.
    Semin Liver Dis. 2024 Mar 18. doi: 10.1055/a-2289-2298.
    PubMed         Abstract available

    Transplant Proc

  47. HO CT, Vu VQ, Dang KK, Pham HM, et al
    Effect of Donors' Biliary Variation on Postoperative Biliary Complications in Living Donor Liver Transplantation: A Single-Center Observational Study in Vietnam.
    Transplant Proc. 2024 Feb 23:S0041-1345(24)00065.
    PubMed         Abstract available

  48. UENO T, Takase K, Deguchi K, Nomura M, et al
    Clinical Implications of Serum Mac-2 Binding Protein in Patients After Living Donor Liver Transplantation for Biliary Atresia.
    Transplant Proc. 2024 Feb 14:S0041-1345(24)00006.
    PubMed         Abstract available

  49. RODRIGUEZ-ESPINOSA D, Morantes L, Garcia J, Broseta JJ, et al
    Long-Term Outcomes of Incidental Liver Malignancies in Simultaneous Liver-Kidney Transplant Recipients.
    Transplant Proc. 2024 Feb 12:S0041-1345(24)00004.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.